These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21221482)

  • 41. Successful translation of pharmacogenetics into the clinic: the abacavir example.
    Phillips E; Mallal S
    Mol Diagn Ther; 2009; 13(1):1-9. PubMed ID: 19351209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive evaluation of two HLA-B17 monoclonal antibodies for flow cytometry-based HLA-B57/B58 screening prior to abacavir prescription.
    Stevens R; Coates E; Street J; Cook E; Darke C
    Int J Immunogenet; 2013 Aug; 40(4):311-5. PubMed ID: 23280011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review.
    Cargnin S; Jommi C; Canonico PL; Genazzani AA; Terrazzino S
    Pharmacogenomics; 2014 May; 15(7):963-76. PubMed ID: 24956250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prospective validation of a pharmacogenetic test: the PREDICT-1 study].
    Muñoz de Benito RM; Arribas López JR
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 6():40-4. PubMed ID: 18680695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study.
    Rauch A; Nolan D; Thurnheer C; Fux CA; Cavassini M; Chave JP; Opravil M; Phillips E; Mallal S; Furrer H;
    Antivir Ther; 2008; 13(8):1019-28. PubMed ID: 19195327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription: clinically useful but is it cost-effective in Singapore?
    Kapoor R; Martinez-Vega R; Dong D; Tan SY; Leo YS; Lee CC; Sung C; Ng OT; Archuleta S; Teo YY
    Pharmacogenet Genomics; 2015 Feb; 25(2):60-72. PubMed ID: 25461248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current trends in screening across ethnicities for hypersensitivity to abacavir.
    Rodriguez-Nóvoa S; Soriano V
    Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI Study).
    Arrizabalaga J; Rodriguez-Alcántara F; Castañer JL; Ocampo A; Podzamczer D; Pulido F; Riera M; Sanz J; Pascual-Bernaldez M; Dal-Re R;
    HIV Clin Trials; 2009; 10(1):48-51. PubMed ID: 19362996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A study of HIV provider attitudes toward HLA-B 5701 testing in the United States.
    Watson ME; Patel LG; Ha B; Wannamaker P; Cuffe R; Shaefer M
    AIDS Patient Care STDS; 2009 Nov; 23(11):957-63. PubMed ID: 19839743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. External quality assessment of HLA-B*5701 reporting: an international multicentre survey.
    Hammond E; Almeida CA; Mamotte C; Nolan D; Phillips E; Schollaardt TA; Gill MJ; Angel JB; Neurath D; Li J; Giulivi T; McIntyre C; Koultchitski G; Wong B; Reis M; Rachlis A; Cole DE; Chew CB; Neifer S; Lalonde R; Roger M; Jeanneau A; Mallal S
    Antivir Ther; 2007; 12(7):1027-32. PubMed ID: 18018760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients.
    Falasca F; Dello Russo C; Mora B; Pirazzoli A; Fantauzzi A; Navarra P; Pizzuti A; De Vito C; Antonelli G; Turriziani O
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):654-7. PubMed ID: 26750774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia.
    Martínez Buitrago E; Oñate JM; García-Goez JF; Álvarez J; Lenis W; Sañudo LM; Rubiano LC
    BMC Infect Dis; 2019 Sep; 19(1):793. PubMed ID: 31500584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypersensitivity reactions in patients treated with abacavir: strategies to avoid such reactions.
    Kapoor S
    AIDS Patient Care STDS; 2008 Oct; 22(10):769. PubMed ID: 18778242
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevalence of human leukocyte antigen HLA-B*57:01 in HIV-infected subjects in the Czech Republic.
    Jilich D; Vraná M; Snopková S; Sedlácek D; Kapla J; Rozsypal H; Kolcáková J; Olbrechtová L; Zjevíková A; Jerhotová Z; Malý M; Stanková M; Machala L
    Cent Eur J Public Health; 2011 Sep; 19(3):128-30. PubMed ID: 22026283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA-B*5701 genetic screening among HIV-1 infected patients in Hong Kong: is this a practical approach in Han-Chinese?
    To SW; Chen JH; Wong KH; Chan KC; Tsang OT; Yam WC
    Int J STD AIDS; 2013 Jan; 24(1):50-2. PubMed ID: 23512513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay.
    Hammond E; Mamotte C; Nolan D; Mallal S
    Tissue Antigens; 2007 Jul; 70(1):58-61. PubMed ID: 17559582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction?
    Bracciale L; Santangelo R; Fanti I; Prosperi M; Colafigli M; Di Giambenedetto S; Marchetti S; Di Franco A; Cauda R; De Luca A
    Antivir Ther; 2009; 14(1):99-101. PubMed ID: 19320242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.
    Kolou M; Poda A; Diallo Z; Konou E; Dokpomiwa T; Zoungrana J; Salou M; Mba-Tchounga L; Bigot A; Ouedraogo AS; Bouyout-Akoutet M; Ekouevi DK; Eholie SP
    BMC Immunol; 2021 Jul; 22(1):48. PubMed ID: 34294032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?
    Phillips EJ
    Clin Infect Dis; 2006 Jul; 43(1):103-5. PubMed ID: 16758425
    [No Abstract]   [Full Text] [Related]  

  • 60. Abacavir-reactive memory T cells are present in drug naïve individuals.
    Lucas A; Lucas M; Strhyn A; Keane NM; McKinnon E; Pavlos R; Moran EM; Meyer-Pannwitt V; Gaudieri S; D'Orsogna L; Kalams S; Ostrov DA; Buus S; Peters B; Mallal S; Phillips E
    PLoS One; 2015; 10(2):e0117160. PubMed ID: 25674793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.